DOH Logo
Immunization Program

CHILD Profile

Immunization Logo
skip main navigation

DTaP - Diphtheria Tetanus acellular Pertussis Vaccine

DTaP is one of four vaccines used to prevent diphtheria, tetanus, and pertussis. DTaP is given to children younger than 7 years of age.

Children under 7 who cannot tolerate the pertussis component in DTaP can get vaccinated with  DT because it does not contain pertussis and is used as a substitute for DTaP for children who cannot tolerate pertussis vaccine. Children should get 5 doses of DTaP, one dose at each of the following ages:

  • 2 months.
  • 4 months.
  • 6 months.
  • 15-18 months.
  • 4-6 years.

Washington State is currently supplying:

  • Sanofi Pasteur DTaP vaccine, brand name, Daptacel. The vaccine has typical availability.
  • Sanofi Pasteur DT vaccine, brand name, DT. The vaccine has typical availability.
  • GlaxoSmithKline DTaP/HepB/IPV vaccine, brand name, Pediarix. The vaccine has typical availability.

Guidelines for the Use of State Supplied Vaccines (PDF 117kb) (04/04/08)
Vaccine Management - Recommendation for Storage and Handling of Vaccines

Vaccine Information Statements:

  • Multiple Vaccines
  • There is no separate vaccine information statement for combination vaccines. For patients receiving Pediarix, please give the vaccine information statements for DTaP, Hepatitis B and IPV.

Fact Sheets:

Related Information:

External Resources:

 

Last Update: 04/17/2008 09:43 AM